We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-3.05%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$52.7B
AUM Growth
-$2.48B
(-4.5%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
2,367
New
187
Increased
1,008
Reduced
966
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$237M |
| 2 |
Pfizer
PFE
|
+$200M |
| 3 |
Moderna
MRNA
|
+$143M |
| 4 |
EPAM Systems
EPAM
|
+$106M |
| 5 |
Gilead Sciences
GILD
|
+$94.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$138M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
AngloGold Ashanti
AU
|
+$112M |
| 4 |
Costco
COST
|
+$111M |
| 5 |
Microsoft
MSFT
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.7% |
| 3 | Industrials | 11.74% |
| 4 | Financials | 11.69% |
| 5 | Consumer Discretionary | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAFE
1701
DELISTED
Safehold Inc.
SAFE
| $677K | ﹤0.01% |
12,202
+1,849
| +18% | +$114K |
|
1702
Allogene Therapeutics
ALLO
$735M
| $672K | ﹤0.01% |
73,717
+44,832
| +155% | +$467K |
|
1703
Insmed
INSM
$29.2B
| $671K | ﹤0.01% |
28,553
| – | – |
|
1704
Rayonier
RYN
$6.44B
| $671K | ﹤0.01% |
17,984
+4,100
| +30% | +$146K |
|
1705
Precision BioSciences
DTIL
$207M
| $669K | ﹤0.01% |
7,238
+6,473
| +846% | +$879K |
|
1706
Penumbra
PEN
$12.8B
| $662K | ﹤0.01% |
3,017
-437
| -13% | -$97.1K |
|
1707
Starwood Property Trust
STWD
$6.13B
| $661K | ﹤0.01% |
27,332
| – | – |
|
|
ARCH
1708
DELISTED
Arch Resources, Inc.
ARCH
| $660K | ﹤0.01% |
4,807
-1,346
| -22% | -$159K |
|
1709
Thryv Holdings
THRY
$92.4M
| $659K | ﹤0.01% |
+23,428
| New | +$735K |
|
1710
Hovnanian Enterprises
HOV
$788M
| $658K | ﹤0.01% |
11,134
-2,479
| -18% | -$224K |
|
|
TECX
1711
Tectonic Therapeutic
TECX
$689M
| $657K | ﹤0.01% |
41,498
+35,184
| +557% | +$727K |
|
1712
Douglas Dynamics
PLOW
$969M
| $655K | ﹤0.01% |
18,949
+2,667
| +16% | +$97K |
|
1713
Lantheus
LNTH
$6.58B
| $653K | ﹤0.01% |
11,802
| – | – |
|
1714
NETGEAR
NTGR
$650M
| $653K | ﹤0.01% |
26,460
| – | – |
|
|
CAMP
1715
DELISTED
CalAmp Corp.
CAMP
| $653K | ﹤0.01% |
3,886
-1,866
| -32% | -$284K |
|
|
AXIA
1716
DELISTED
AXIA Energia
AXIA
| $651K | ﹤0.01% |
103,996
-21,704
| -17% | -$112K |
|
1717
Unisys
UIS
$206M
| $651K | ﹤0.01% |
30,141
-12,830
| -30% | -$260K |
|
1718
Agilysys
AGYS
$2.98B
| $650K | ﹤0.01% |
16,307
-13,739
| -46% | -$552K |
|
1719
The Bancorp
TBBK
$2.84B
| $650K | ﹤0.01% |
22,944
| – | – |
|
1720
eGain
EGAN
$199M
| $648K | ﹤0.01% |
55,953
-92,391
| -62% | -$1.04M |
|
1721
Amcor
AMCR
$21.6B
| $647K | ﹤0.01% |
11,436
+6,051
| +112% | +$353K |
|
1722
MGP Ingredients
MGPI
$382M
| $647K | ﹤0.01% |
7,560
+76
| +1% | +$6.12K |
|
1723
TFS Financial
TFSL
$4.89B
| $646K | ﹤0.01% |
38,902
-19
| -0% | -$327 |
|
1724
Gentherm
THRM
$1.26B
| $645K | ﹤0.01% |
8,834
-6,804
| -44% | -$567K |
|
1725
Alarm.com
ALRM
$2.73B
| $644K | ﹤0.01% |
9,693
-1,573
| -14% | -$111K |
|
Similar funds
VGA
AQR Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, AQR Capital Management held 2,367 positions worth $52.7B, down 4.5% from $55.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
AQR Capital Management's Q1 2022 filing shows 187 new, 1,008 increased, 966 reduced and 158 closed positions. Its largest new stake was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M. The largest sale was Target, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
- AQR Capital Management's largest Q1 2022 buy was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M.
- AQR Capital Management added most to Meta Platforms (Facebook) in Q1 2022, an estimated $237M increase.
- AQR Capital Management's biggest Q1 2022 reduction was Target, cutting an estimated $138M.
- AQR Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $25.4M.
- AQR Capital Management's ten largest holdings make up 16% of its $52.7B portfolio in Q1 2022.
- AQR Capital Management opened 187 new positions and closed 158 in Q1 2022.
- AQR Capital Management's portfolio value fell 4.5% quarter-over-quarter to $52.7B.
Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.